Showing results (1621-1630 of 1,667) with videos related to

Sort By:
Pageof 167
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
Nature Communications|April 22, 2025
Rapid flips between warm and cold extremes in a warming worldSijia Wu, Ming Luo, Gabriel Ngar-Cheung Lau, et al.
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
Respiratory Research|September 30, 2020
Association of diurnal temperature range with daily hospitalization for exacerbation of chronic respiratory diseases in 21 cities, ChinaZihui Wang, Yumin Zhou, Ming Luo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 29, 2022
Self-Reported Insufficient Sleep Is Associated With Clinical and Inflammatory Features of Asthma: A Prospective Cohort StudyChang Yong Wang, Ji Wang, Li Zhang, et al.
International Journal of Biological Macromolecules|July 29, 2024
Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammationXiu-Tao Fu, Jing-Bo Qie, Jia-Feng Chen, et al.
The New England Journal of Medicine|February 4, 2011
Safety of influenza A (H1N1) vaccine in postmarketing surveillance in ChinaXiao-Feng Liang, Li Li, Da-Wei Liu, et al.
Nucleic Acids Research|April 19, 2013
Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerizationAntonio Ariza, Sian J Tanner, Cheryl T Walter, et al.
International Journal of Biological Sciences|August 27, 2025
<i>MALAT1</i> promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttlingZe-Bang Du, Xin-Mou Wu, Tun Han, et al.
Hepatology International|August 25, 2025
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort studyNingning Zhang, Kaipeng Liu, Yuexi Yu, et al.
Pageof 167